Gland Pharma Ltd (GLAND) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 1003443, "name": "Gland Pharma", "stock_name": "Gland Pharma", "full_name": "Gland Pharma Ltd", "name_url": "stocks-analysis/gland-pharma", "exchange": 1, "exchangecode": "", "country_id": 34, "currency": "INR", "cmp": "1,895.70", "chg": -1.8, "chgp": "-0.09%", "dir": -1, "prev_price": "1,897.50", "mcapval": "31,600.00 Cr", "mcap": "Small Cap", "scripcode": 543245, "symbol": "GLAND", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "", "isin": "INE068V01023", "curr_date": "Feb 03", "curr_time": "", "bse_nse_vol": "3.87 lacs", "exc_status": "Active", "traded_date": "Feb 03, 2026", "traded_date_str": "2026 02 03", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/gland-pharma-1003443-1&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Gland Pharma Ltd Upgraded to Hold as Financial and Technical Trends Improve", "link": "https://www.marketsmojo.com/news/stock-recommendation/gland-pharma-ltd-upgraded-to-hold-as-financial-and-technical-trends-improve-3817404", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/GlandPharmaLtd_mojoScore_3817404.png", "date": "2026-02-03 08:23:07", "description": "Gland Pharma Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a marked improvement across financial performance, technical indicators, and valuation metrics. The pharmaceutical company’s recent quarterly results and market behaviour have prompted analysts to revise their outlook, signalling cautious optimism amid a very expensive valuation backdrop." }, { "title": "Gland Pharma Ltd Shows Mixed Technical Signals Amid Price Momentum Shift", "link": "https://www.marketsmojo.com/news/stocks-in-action/gland-pharma-ltd-shows-mixed-technical-signals-amid-price-momentum-shift-3817284", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/GlandPharmaLtd_technicaldot_3817284.png", "date": "2026-02-03 08:04:58", "description": "Gland Pharma Ltd has exhibited a notable shift in its technical parameters, moving from a mildly bearish stance to a more sideways trend, reflecting a complex interplay of momentum indicators. The stock’s recent price action, combined with mixed signals from MACD, RSI, and moving averages, suggests a cautious outlook for investors amid ongoing volatility in the Pharmaceuticals & Biotechnology sector." }, { "title": "Gland Pharma Gains 9.73%: 5 Key Factors Driving the Week’s Rally", "link": "https://www.marketsmojo.com/news/stocks-in-action/gland-pharma-gains-973-5-key-factors-driving-the-weeks-rally-3812726", "imagepath": "", "date": "2026-01-31 12:00:12", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>27 Jan:</strong> Stock opens week at Rs.1,675.35, down 0.39% despite Sensex rise</p>\n <p><strong>28 Jan:</strong> Q3 FY26 results reveal record revenue and profit</p>\n <p><strong>29 Jan:</strong> Significant gap-up and intraday high of Rs.1,849 with 7.6% surge</p>\n <p><strong>30 Jan:</strong> Technical momentum shifts amid mixed indicator signals, stock closes at Rs.1,845.60</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,681.95</div></div>\n <div class=\"stat-item\"><div class=\"s..." }, { "title": "Gland Pharma Ltd Sees Technical Momentum Shift Amid Mixed Indicator Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/gland-pharma-ltd-sees-technical-momentum-shift-amid-mixed-indicator-signals-3810678", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/GlandPharmaLtd_technicaldot_3810678.png", "date": "2026-01-30 08:02:47", "description": "Gland Pharma Ltd has experienced a notable shift in price momentum, reflected in a complex array of technical indicators that suggest a transition from bearish to mildly bearish trends. Despite a robust day change of 6.75%, the stock’s technical parameters present a nuanced picture, with some indicators signalling caution while others hint at potential recovery. This article analyses the latest technical data, placing Gland Pharma’s performance in the context of broader market movements and sectoral trends." }, { "title": "Are Gland Pharma Ltd latest results good or bad?", "link": "https://www.marketsmojo.com/news/result-analysis/are-gland-pharma-ltd-latest-results-good-or-bad-3810125", "imagepath": "", "date": "2026-01-29 19:25:24", "description": "Gland Pharma Ltd's latest financial results for Q3 FY26 reveal a complex picture of operational performance. The company reported a net profit of ₹279.06 crores, reflecting a year-on-year growth of 36.30%, while revenue reached ₹1,695.36 crores, marking a 22.49% increase compared to the same quarter last year. This revenue figure represents a sequential growth of 14.02% from the previous quarter, indicating strong demand, particularly in its injectable portfolio and key export markets like the United States.\n\nHowever, the operating margin has come under pressure, decreasing to 19.07%, down 201 basis points year-on-year. This decline is attributed to rising employee costs and increased manufacturing expenses as Gland Pharma scales its production capacity. Despite the growth in revenue and net profit margins, which improved to 16.46% from 14.79% in the prior year, the reliance on exceptional other income, whi..." }, { "title": "Gland Pharma Ltd Hits Intraday High with 7.6% Surge on 29 Jan 2026", "link": "https://www.marketsmojo.com/news/stocks-in-action/gland-pharma-ltd-hits-intraday-high-with-76-surge-on-29-jan-2026-3808981", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/GlandPharmaLtd_priceRelatedfactors_3808981.png", "date": "2026-01-29 09:32:58", "description": "Gland Pharma Ltd recorded a robust intraday performance on 29 Jan 2026, surging to an intraday high of Rs 1849, marking a 9.49% rise from its previous close. The stock outperformed its sector and broader market indices, reflecting significant trading momentum and volatility throughout the session." }, { "title": "Gland Pharma Ltd Opens Strong with Significant Gap Up on 29 Jan 2026", "link": "https://www.marketsmojo.com/news/stocks-in-action/gland-pharma-ltd-opens-strong-with-significant-gap-up-on-29-jan-2026-3808967", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/GlandPharmaLtd_gapup_3808967.png", "date": "2026-01-29 09:31:33", "description": "Gland Pharma Ltd commenced trading on 29 Jan 2026 with a significant gap up, opening 7.72% higher than its previous close. This strong start underscores a positive market sentiment towards the pharmaceutical company amid a backdrop of notable outperformance relative to its sector and benchmark indices." }, { "title": "Gland Pharma Ltd Reports Strongest Quarterly Performance Amid Positive Financial Trend", "link": "https://www.marketsmojo.com/news/stocks-in-action/gland-pharma-ltd-reports-strongest-quarterly-performance-amid-positive-financial-trend-3808624", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/GlandPharmaLtd_fintrenddot_3808624.png", "date": "2026-01-29 08:00:25", "description": "Gland Pharma Ltd has delivered its highest quarterly financial results to date in the December 2025 quarter, signalling a marked improvement in its financial trajectory. The company’s net sales, profitability, and earnings per share have all reached record levels, reflecting a positive shift from a previously flat financial trend and prompting a downgrade in its Mojo Grade from Hold to Sell." }, { "title": "Gland Pharma Q3 FY26: Strong Quarter Masked by Valuation Concerns", "link": "https://www.marketsmojo.com/news/result-analysis/gland-pharma-q3-fy26-strong-quarter-masked-by-valuation-concerns-3808299", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/GlandPharma_quaterlyResult_3808299.png", "date": "2026-01-28 19:03:06", "description": "Gland Pharma Ltd., the Hyderabad-based injectable pharmaceuticals specialist, delivered a robust performance in Q3 FY26 with net profit surging 36.30% year-on-year to ₹279.06 crores, marking its strongest quarterly showing in recent history. However, the stock's muted response—trading at ₹1,688.70 with a modest 0.80% gain—reflects investor caution over stretched valuations, with shares trading at 35 times trailing earnings despite persistent profitability concerns and declining returns on equity." } ], "total": 334, "sid": "1003443", "stock_news_url": "https://www.marketsmojo.com/news/gland-pharma-1003443" }, "announcements": "", "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Gland Pharma Ltd has declared <strong>1800%</strong> dividend, ex-date: 14 Aug 25", "dt": "2025-08-14", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

27 Jan: Stock opens week at Rs.1,675.35, down 0.39% despite Sensex rise

28 Jan: Q3 FY26 results reveal record revenue and profit

29 Jan: Significant gap-up and intraday high of Rs.1,849 with 7.6% surge

30 Jan: Technical momentum shifts amid mixed indicator signals, stock closes at Rs.1,845.60

Week Open

Rs.1,681.95

Read full news article

Gland Pharma Ltd Sees Technical Momentum Shift Amid Mixed Indicator Signals

2026-01-30 08:02:47

Gland Pharma Ltd has experienced a notable shift in price momentum, reflected in a complex array of technical indicators that suggest a transition from bearish to mildly bearish trends. Despite a robust day change of 6.75%, the stock’s technical parameters present a nuanced picture, with some indicators signalling caution while others hint at potential recovery. This article analyses the latest technical data, placing Gland Pharma’s performance in the context of broader market movements and sectoral trends.

Read full news article

Are Gland Pharma Ltd latest results good or bad?

2026-01-29 19:25:24

Gland Pharma Ltd's latest financial results for Q3 FY26 reveal a complex picture of operational performance. The company reported a net profit of ₹279.06 crores, reflecting a year-on-year growth of 36.30%, while revenue reached ₹1,695.36 crores, marking a 22.49% increase compared to the same quarter last year. This revenue figure represents a sequential growth of 14.02% from the previous quarter, indicating strong demand, particularly in its injectable portfolio and key export markets like the United States. However, the operating margin has come under pressure, decreasing to 19.07%, down 201 basis points year-on-year. This decline is attributed to rising employee costs and increased manufacturing expenses as Gland Pharma scales its production capacity. Despite the growth in revenue and net profit margins, which improved to 16.46% from 14.79% in the prior year, the reliance on exceptional other income, whi...

Read full news article

Gland Pharma Ltd Hits Intraday High with 7.6% Surge on 29 Jan 2026

2026-01-29 09:32:58

Gland Pharma Ltd recorded a robust intraday performance on 29 Jan 2026, surging to an intraday high of Rs 1849, marking a 9.49% rise from its previous close. The stock outperformed its sector and broader market indices, reflecting significant trading momentum and volatility throughout the session.

Read full news article

Gland Pharma Ltd Opens Strong with Significant Gap Up on 29 Jan 2026

2026-01-29 09:31:33

Gland Pharma Ltd commenced trading on 29 Jan 2026 with a significant gap up, opening 7.72% higher than its previous close. This strong start underscores a positive market sentiment towards the pharmaceutical company amid a backdrop of notable outperformance relative to its sector and benchmark indices.

Read full news article

Gland Pharma Ltd Reports Strongest Quarterly Performance Amid Positive Financial Trend

2026-01-29 08:00:25

Gland Pharma Ltd has delivered its highest quarterly financial results to date in the December 2025 quarter, signalling a marked improvement in its financial trajectory. The company’s net sales, profitability, and earnings per share have all reached record levels, reflecting a positive shift from a previously flat financial trend and prompting a downgrade in its Mojo Grade from Hold to Sell.

Read full news article

Gland Pharma Q3 FY26: Strong Quarter Masked by Valuation Concerns

2026-01-28 19:03:06

Gland Pharma Ltd., the Hyderabad-based injectable pharmaceuticals specialist, delivered a robust performance in Q3 FY26 with net profit surging 36.30% year-on-year to ₹279.06 crores, marking its strongest quarterly showing in recent history. However, the stock's muted response—trading at ₹1,688.70 with a modest 0.80% gain—reflects investor caution over stretched valuations, with shares trading at 35 times trailing earnings despite persistent profitability concerns and declining returns on equity.

Read full news article